Pharmaceutical manufacturer Roche Canada will invest $190 million to construct a new research and development facility in Mississauga, the company announced last week. According to information sent in an email by Corporate Affairs Manager Mike Vesik, "The Mississauga site will coordinate the execution of global clinical trials both within the Roche affiliate network that support more than 60 countries world-wide, and as outsourced trials working with Contract Research Organizations."
"We are extremely pleased to bring global Pharmaceutical Development opportunities to Ontario," Roche Canada President and CEO Ronnie Miller said in his announcement. "We have built a respected clinical expertise within the Roche global network, and this new capability will firmly establish Roche Canada, and the province of Ontario, as a global hub for life sciences and biopharmaceuticals."
The facility will be one of six global research centres for the company, developing new medicines, taking them through testing and trials and bringing them to market. The company estimates the facility will create 200 new jobs through direct employment. Vesik says that the jobs be for both scientists to lead and manage clinical trials and for support staff, and adds that the talent pool in the GTA and the area's school's is one of the key assets of the plant's location.
Writer: Edward Keenan
Source: Mike Vesik, Roche Canada